China SXT Pharmaceuticals Inc (SXTC)
1.02
-0.02
(-1.92%)
USD |
NASDAQ |
May 02, 11:49
China SXT Pharmaceuticals Revenue (TTM): 1.703M for Sept. 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | 1.703M |
| March 31, 2023 | 1.972M |
| September 30, 2022 | 2.783M |
| March 31, 2022 | 2.602M |
| September 30, 2021 | 1.945M |
| March 31, 2021 | 4.778M |
| Date | Value |
|---|---|
| September 30, 2020 | 5.808M |
| March 31, 2020 | 5.162M |
| September 30, 2019 | 6.310M |
| March 31, 2019 | 7.012M |
| September 30, 2018 | 7.047M |
| March 31, 2018 | 7.019M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.703M
Minimum
Sep 2023
6.310M
Maximum
Sep 2019
3.674M
Average
2.783M
Median
Sep 2022
Revenue (TTM) Benchmarks
| Jin Medical International Ltd | 19.82M |
| Sinovac Biotech Ltd | 448.27M |
| CASI Pharmaceuticals Inc | 33.88M |
| Zai Lab Ltd | 266.72M |
| I-MAB | -35.63M |